Acceptability of cannabidiol in patients with psychosis.

Edward ChesneyDoga LamperMillie LloydDominic OliverEmily HirdPhilip McGuire

Published in: Therapeutic advances in psychopharmacology (2022)

Most patients with psychosis regard CBD as an acceptable treatment. Although CBD has not yet been approved as a treatment for psychosis, many patients are aware of it through the presence of CBD in cannabis and in health supplements. When added to the emerging evidence of its efficacy and the low risk of side effects, the high acceptability of CBD underlines its therapeutic potential.

Keyphrases

end stage renal disease
public health
ejection fraction
chronic kidney disease
mental health
risk assessment
combination therapy
patient reported outcomes
health information